graph-pad prism version 5.03 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
graph-pad prism version 5.03
Graph Pad Prism Version 5.03, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph-pad+prism+version+5%2E03/graphpad+prism+software/pmc10675340-91-35-39
Average 90 stars, based on 1 article reviews
Graph Pad Prism Version 5.03, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph-pad+prism+version+5%2E03/graphpad+prism+software/pmc10675340-91-35-39
Average 90 stars, based on 1 article reviews
graph-pad prism version 5.03 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: Preparation, Radiolabeling with 68 Ga/ 177 Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting. Article Snippet: Triple-negative MDA-MB-231 and estrogen receptor-positive MCF7 breast cancer cell lines were used to determine saturation binding and the binding affinity (Kd) profile was calculated by fitting the data with nonlinear regression using Article Title: Preparation, Radiolabeling with 68 Ga/ 177 Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting Article Snippet: Triple-negative MDA-MB-231 and estrogen receptor-positive MCF7 breast cancer cell lines were used to determine saturation binding and the binding affinity ( K d ) profile was calculated by fitting the data with nonlinear regression using Binding Assay:Article Title: Preparation, Radiolabeling with 68 Ga/ 177 Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting. Article Snippet: Triple-negative MDA-MB-231 and estrogen receptor-positive MCF7 breast cancer cell lines were used to determine saturation binding and the binding affinity (Kd) profile was calculated by fitting the data with nonlinear regression using Article Title: Preparation, Radiolabeling with 68 Ga/ 177 Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting Article Snippet: Triple-negative MDA-MB-231 and estrogen receptor-positive MCF7 breast cancer cell lines were used to determine saturation binding and the binding affinity ( K d ) profile was calculated by fitting the data with nonlinear regression using |